The employees at WuXi Biologics have once again shown their commitment to the local community with their fourth annual ...

At the JP Morgan Conference 2025, CEO Chen said the potential of the Biosecure Act passing has had only a minimal chilling ...

WuXi Biologics subsidiary WuXi Vaccines has agreed to sell its vaccine manufacturing facility in Dundalk, Ireland, to MSD for approximately $500m. Expected to close in the first half of 2025, the deal ...

The pharmaceutical firm MSD is buying out the WuXi Vaccines manufacturing plant in Dundalk, in a €500m deal. The American company says that in addition to the 150 jobs at the Dundalk facility ...

Pharmaceutical firm MSD has agreed a deal to buy the WuXi Vaccines manufacturing facility in Dundalk, Co Louth as part of its long-term plans in Ireland. MSD said the deal is worth €500m and ...

The Dundalk site was WuXi's first manufacturing investment in Europe and the company’s first investment of this scale outside of China The MSD site in Dundalk, Co Louth. The Dundalk site will ...

Pharma giant MSD is buying the Dundalk-based vaccines plant of Chinese rival Wuxi in a €500 million deal. Wuxi invested €200 million in 2019 to build the plant, which currently employs 200 ...

The New Jersey company was a natural buyer of the facility as it was the lone client WuXi Biologics served at the site in Dundalk, executing a 20-year contract to produce vaccines worth $150 ...

The WuXi Biologics facility is located in Dundalk, Co Louth, in the IDA Science and Technology Park. WuXi invested €200 million in 2019 to build the plant, which currently employs 200 people ...

Merck's €500 million investment in Dundalk adds to €3 billion invested ... Over 3,000 people are employed across the network. Merck and WuXi Vaccines are now entering a formal handover process ...

Pharmaceutical giant Merck, which operates as MSD outside of the U.S., is to acquire the WuXi Vaccines manufacturing plant in Dundalk as part of a €500M deal, bringing the U.S.-based company ...

The pharmaceutical firm MSD is buying out the WuXi Vaccines manufacturing plant in Dundalk, in a €500m deal. The American company says that in addition to the 150 jobs at the Dundalk facility, it is ...